Literature DB >> 1702708

Primary structure and functional properties of cobra (Naja naja naja) venom Kunitz-type trypsin inhibitor.

J Shafqat1, O U Beg, S J Yin, Z H Zaidi, H Jörnvall.   

Abstract

A trypsin inhibitor from the venom of the cobra Naja naja naja has been isolated by a single step of reverse-phase high-performance liquid chromatography. The protein strongly inhibits trypsin (Ki = 3.5 pM). The primary structure was determined by peptide analysis of the [14C]carboxymethylated inhibitor. The 57-residue polypeptide chain belongs to the family of Kunitz-type inhibitors, and exhibits 42% residue identity with bovine pancreatic trypsin inhibitor. The structure shows only 70% identity with the corresponding peptide from the Capa cobra (Naja nevia), establishing that the inhibitor molecule exhibits extensive variations. Functionally, a basic residue at position P3' correlates with strong inhibition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702708     DOI: 10.1111/j.1432-1033.1990.tb15622.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

Review 1.  Privileged frameworks from snake venom.

Authors:  T A Reeks; B G Fry; P F Alewood
Journal:  Cell Mol Life Sci       Date:  2015-02-19       Impact factor: 9.261

2.  Suppression of ADAM17-mediated Lyn/Akt pathways induces apoptosis of human leukemia U937 cells: Bungarus multicinctus protease inhibitor-like protein-1 uncovers the cytotoxic mechanism.

Authors:  Wen-Hsin Liu; Long-Sen Chang
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

3.  Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom.

Authors:  M Brillard-Bourdet; V Nguyên; M Ferrer-di Martino; F Gauthier; T Moreau
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

4.  Mutagenesis studies on the N-terminus and Thr54 of Naja naja atra (Taiwan cobra) chymotrypsin inhibitor.

Authors:  Fang-Jiun Yan; Ching-Ping Chen; Yun-Ching Cheng; Long-Sen Chang
Journal:  Protein J       Date:  2006-06       Impact factor: 2.371

5.  Transcriptomic analysis of the venom gland of the red-headed krait (Bungarus flaviceps) using expressed sequence tags.

Authors:  Ang Swee Siang; Robin Doley; Freek J Vonk; R Manjunatha Kini
Journal:  BMC Mol Biol       Date:  2010-03-29       Impact factor: 2.946

6.  Purification and characterization of tenerplasminin-1, a serine peptidase inhibitor with antiplasmin activity from the coral snake (Micrurus tener tener) venom.

Authors:  Jeilyn Vivas; Carlos Ibarra; Ana M Salazar; Ana G C Neves-Ferreira; Elda E Sánchez; Jonás Perales; Alexis Rodríguez-Acosta; Belsy Guerrero
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-09-28       Impact factor: 3.228

Review 7.  Brown spider (Loxosceles genus) venom toxins: tools for biological purposes.

Authors:  Olga Meiri Chaim; Dilza Trevisan-Silva; Daniele Chaves-Moreira; Ana Carolina M Wille; Valéria Pereira Ferrer; Fernando Hitomi Matsubara; Oldemir Carlos Mangili; Rafael Bertoni da Silveira; Luiza Helena Gremski; Waldemiro Gremski; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2011-03-22       Impact factor: 4.546

Review 8.  Protease inhibitors from marine venomous animals and their counterparts in terrestrial venomous animals.

Authors:  Caroline B F Mourão; Elisabeth F Schwartz
Journal:  Mar Drugs       Date:  2013-06-14       Impact factor: 5.118

9.  Comparative venom gland transcriptomics of Naja kaouthia (monocled cobra) from Malaysia and Thailand: elucidating geographical venom variation and insights into sequence novelty.

Authors:  Kae Yi Tan; Choo Hock Tan; Lawan Chanhome; Nget Hong Tan
Journal:  PeerJ       Date:  2017-04-05       Impact factor: 2.984

10.  Proteomic Characterization of Two Medically Important Malaysian Snake Venoms, Calloselasma rhodostoma (Malayan Pit Viper) and Ophiophagus hannah (King Cobra).

Authors:  Sugita Kunalan; Iekhsan Othman; Sharifah Syed Hassan; Wayne C Hodgson
Journal:  Toxins (Basel)       Date:  2018-10-26       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.